AJNS Australia–China Biopharma Collaboration Initiative

Australian Journal of Natural Sciences (AJNS), an international peer-reviewed open-access journal (ISSN 3083-3515), is dedicated to the dissemination and exchange of high-quality research in natural sciences and medicine. We have long focused on the potential for collaboration between Australia and China in the biopharmaceutical sector and are aligned with Australia’s national innovation and R&D policy framework.

To facilitate cross-border research and clinical collaboration between Australia and China, and to support biopharmaceutical researchers and enterprises in establishing research and clinical activities in Australia, AJNS is launching the Australia–China Biopharma Collaboration Initiative.

We maintain extensive networks of hospitals, physicians, universities, and research institutions, including leading organisations within Melbourne’s Parkville biomedical precinct, enabling efficient project implementation and full-chain execution.

How the Australian Government’s R&D Tax Incentive Supports Your Research

For eligible small enterprises (annual turnover below AUD 20 million), the Australian Government offers up to 43.5% cash rebate under the R&D Tax Incentive program, including refundable offsets for non-profitable companies. This policy significantly reduces net R&D costs, eases cash flow pressure, and enhances global competitiveness, with Australian clinical data broadly accepted by major international regulatory agencies, including the FDA and EMA.

Our Support

Priority Publication Channel
We welcome submissions of experimental designs, clinical data, and research outcomes to AJNS, with priority peer review and publication support.

Complementary Implementation Assistance
Through our networks, we provide guidance on Australian subsidiary establishment, hospital and CRO connections, and access to small-scale funding opportunities.

Summit & Exposure
Outstanding researchers will be invited to speak or present at the Australia–China Clinical Innovation Summit.

Call for Submissions and Collaboration

We sincerely invite biopharmaceutical researchers, enterprises, and teams to submit to AJNS or contact us to explore collaboration opportunities. Your work will receive professional review, global visibility, and Australia–China implementation resources.

Contact

Email: info@ansf.com.au

Disclaimer

This initiative is based on publicly available Australian Government policies (AusIndustry/ATO). AJNS/ANSF does not provide formal legal or tax advice; final outcomes are subject to official review. Resource partnerships are subject to actual availability.